大葉大學圖書館 |

Safety pharmacology in pharmaceutical development[electronic resource] :approval and post marketing surveillance /

Record Type:	Language materials, printed : Monograph/item
[NT 15000414]:	615.7/04
Title/Author:	Safety pharmacology in pharmaceutical development : approval and post marketing surveillance // Shayne C. Gad.
Author:	Gad, Shayne C.,
other author:	Gad, Shayne C.,
Published:	Boca Raton, FL : : CRC Press,, c2012.
Description:	1 online resource (xv, 197 p.) : : ill.
Notes:	Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
Subject:	Drugs - Toxicology.
Subject:	Drugs - Safety measures.
Subject:	Drug development - Safety measures.
Subject:	Drug Evaluation, Preclinical.
Subject:	Drug Approval.
Subject:	Product Surveillance, Postmarketing.
Subject:	Toxicity Tests.
ISBN:	9781439845684 (electronic bk.)
[NT 15000227]:	Includes bibliographical references and index.
[NT 15000228]:	Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.
[NT 15000229]:	"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
Online resource:	http://www.crcnetbase.com/isbn/9781439845684

Safety pharmacology in pharmaceutical development[electronic resource] :approval and post marketing surveillance /
Gad, Shayne C.,1948-

Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /[electronic resource] :Shayne C. Gad. - 2nd ed. - Boca Raton, FL :CRC Press,c2012. - 1 online resource (xv, 197 p.) :ill.

Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.

Includes bibliographical references and index.

Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.

"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.

ISBN: 9781439845684 (electronic bk.)

LCCN: 2012009446Subjects--Topical Terms:

431493
Drugs
--Toxicology.

LC Class. No.: RA1238 / .G333 2012

Dewey Class. No.: 615.7/04

National Library of Medicine Call No.: 2012 F-386

Safety pharmacology in pharmaceutical development[electronic resource] :approval and post marketing surveillance /
LDR:02030cam a2200325 a 4500 001 457149
003 OCoLC
005 20121015081754.0
006 m o d
007 cr |n|---|||||
008 161227s2012 flua ob 001 0 eng
010 $a 2012009446
020 $a 9781439845684 (electronic bk.)
020 $z 9781439845677 (hardback)
035 $a (OCoLC)761380929
035 $a 761380929
040 $a DNLM/DLC $b eng $c DLC $d YDX $d NLM $d UKMGB $d YDXCP $d OCLCO $d ZWZ $d CDX $d MXC
050 4 $a RA1238 $b .G333 2012
060 0 0 $a 2012 F-386
060 1 0 $a QV 771
082 0 0 $a 615.7/04 $2 23
100 1 $a Gad, Shayne C., $d 1948- $t Safety evaluation of medical devices. $3 438445
245 1 0 $a Safety pharmacology in pharmaceutical development $h [electronic resource] : $b approval and post marketing surveillance / $c Shayne C. Gad.
250 $a 2nd ed.
260 $a Boca Raton, FL : $b CRC Press, $c c2012.
300 $a 1 online resource (xv, 197 p.) : $b ill.
500 $a Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
504 $a Includes bibliographical references and index.
505 0 $a Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.
520 $a "This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
588 $a Description based on print version record.
650 0 $a Drugs $x Toxicology. $3 431493
650 0 $a Drugs $x Safety measures. $3 519074
650 0 $a Drug development $x Safety measures. $3 657343
650 1 2 $a Drug Evaluation, Preclinical. $3 431418
650 2 2 $a Drug Approval. $3 553525
650 2 2 $a Product Surveillance, Postmarketing. $3 520490
650 2 2 $a Toxicity Tests. $3 437991
700 1 $a Gad, Shayne C., $d 1948- $t Safety evaluation of medical devices. $3 438445
856 4 0 $u http://www.crcnetbase.com/isbn/9781439845684